T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Oneok
OKE
$59.9B
| $33.4M | ﹤0.01% |
602,016
-64,476
| -10% | -$4.18M |
|
1002
United Parks & Resorts
PRKS
$2.04B
| $33.3M | ﹤0.01% |
753,634
-242,791
| -24% | -$14.1M |
|
1003
Omega Healthcare
OHI
$14.1B
| $33.3M | ﹤0.01% |
1,180,331
+225,225
| +24% | +$6.41M |
|
1004
Gen Digital
GEN
$17B
| $33.2M | ﹤0.01% |
1,513,692
-8,577,804
| -85% | -$211M |
|
|
BLFY
1005
DELISTED
Blue Foundry Bancorp
BLFY
| $33.2M | ﹤0.01% |
2,770,978
+24,344
| +0.9% | +$301K |
|
|
ARCE
1006
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $33.2M | ﹤0.01% |
2,221,419
+4,923
| +0.2% | +$86.1K |
|
1007
Bio-Rad Laboratories Class A
BIO
$9.53B
| $33.1M | ﹤0.01% |
66,939
-3,445
| -5% | -$1.79M |
|
1008
SM Energy
SM
$8.03B
| $33.1M | ﹤0.01% |
968,046
+122,541
| +14% | +$4.98M |
|
1009
C4 Therapeutics
CCCC
$522M
| $33M | ﹤0.01% |
4,383,163
+5,791
| +0.1% | +$51K |
|
1010
John Marshall Bancorp
JMSB
$328M
| $32.7M | ﹤0.01% |
+1,452,547
| New | +$37.7M |
|
1011
VanEck Oil Services ETF
OIH
$2B
| $32.7M | ﹤0.01% |
140,629
+32,738
| +30% | +$8.97M |
|
|
ABMD
1012
DELISTED
Abiomed Inc
ABMD
| $32.7M | ﹤0.01% |
132,042
-4,492
| -3% | -$1.21M |
|
|
ISEE
1013
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $32.6M | ﹤0.01% |
3,390,140
-1,220,136
| -26% | -$15.3M |
|
|
FRGI
1014
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $32.5M | ﹤0.01% |
4,547,280
+43,964
| +1% | +$311K |
|
1015
Dutch Bros
BROS
$9.09B
| $32.4M | ﹤0.01% |
1,024,255
+49,097
| +5% | +$2.01M |
|
1016
Teradata
TDC
$2.57B
| $32.2M | ﹤0.01% |
869,894
-52,176
| -6% | -$2.08M |
|
|
AVLR
1017
DELISTED
Avalara, Inc.
AVLR
| $32.2M | ﹤0.01% |
455,986
-126,573
| -22% | -$10.4M |
|
1018
Expeditors International
EXPD
$24.2B
| $32.1M | ﹤0.01% |
329,725
-19,193
| -6% | -$1.97M |
|
1019
Ryman Hospitality Properties
RHP
$7.92B
| $32.1M | ﹤0.01% |
421,772
+44,911
| +12% | +$3.96M |
|
|
ENV
1020
DELISTED
ENVESTNET, INC.
ENV
| $32M | ﹤0.01% |
607,226
+4,461
| +0.7% | +$305K |
|
1021
Take-Two Interactive
TTWO
$46.2B
| $31.9M | ﹤0.01% |
260,667
+43,426
| +20% | +$5.53M |
|
1022
Timken Company
TKR
$9.25B
| $31.9M | ﹤0.01% |
601,816
-321,769
| -35% | -$18.8M |
|
1023
Warner Music
WMG
$13.4B
| $31.8M | ﹤0.01% |
1,305,792
-3,093
| -0.2% | -$92.3K |
|
1024
Seer Inc
SEER
$115M
| $31.8M | ﹤0.01% |
3,548,336
-522,691
| -13% | -$4.78M |
|
1025
Addus HomeCare
ADUS
$2.17B
| $31.7M | ﹤0.01% |
380,730
+2,635
| +0.7% | +$221K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.